Aldosterone Synthase Inhibitors and Mineralocorticoid Receptor Antagonists: Competitors or Collaborators?
Circulation · 2024
DOI: 10.1161/circulationaha.123.066314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, 2024. Verfasst von Bertram Pitt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Medicine, University of Michigan, Ann Arbor (B.P.). Hauptthemen laut MEDLINE: Aldosterone, Hypertension. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, School of Medicine, University of Michigan, Ann Arbor (B.P.).
- Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (G.H.W.).
ORCID-Profile: Bertram Pitt, Gordon H Williams
Zitieren
APA
Pitt, B., & Williams, G. H. (2024). Aldosterone Synthase Inhibitors and Mineralocorticoid Receptor Antagonists: Competitors or Collaborators?. Circulation. https://doi.org/10.1161/circulationaha.123.066314
Vancouver
Pitt B, Williams GH. Aldosterone Synthase Inhibitors and Mineralocorticoid Receptor Antagonists: Competitors or Collaborators?. Circulation. 2024. doi:10.1161/circulationaha.123.066314
BibTeX
@article{Pitt2024,
author = {Pitt, Bertram and Williams, Gordon H},
title = {Aldosterone Synthase Inhibitors and Mineralocorticoid Receptor Antagonists: Competitors or Collaborators?},
journal = {Circulation},
year = {2024},
doi = {10.1161/circulationaha.123.066314}
}
EUVIMED